Key statistics
On Monday, Boundless Bio Inc (BOLD:NSQ) closed at 1.15, 19.12% above the 52 week low of 0.9612 set on Feb 05, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.18 |
|---|---|
| High | 1.20 |
| Low | 1.13 |
| Bid | 1.13 |
| Offer | 1.21 |
| Previous close | 1.16 |
| Average volume | 221.99k |
|---|---|
| Shares outstanding | 22.39m |
| Free float | 19.83m |
| P/E (TTM) | -- |
| Market cap | 25.63m USD |
| EPS (TTM) | -16.06 USD |
Data delayed at least 15 minutes, as of Feb 09 2026 21:00 GMT.
More ▼
Announcements
- Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
- Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway
- Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
- Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights
- Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
- Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights
- Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
- Boundless Bio Announces Portfolio Prioritization and Runway Extension
- Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights
- Boundless Bio to Participate in the Needham Virtual Healthcare Conference
More ▼
